Overview Filana Therapeutics, Inc. (formerly Cassava Sciences, Inc.) is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to develop transformative medicines to improve the lives of patients with central nervous system(CNS) disorders, such as Tuberous Sclerosis Complex (TSC)-related epilepsy and other diseases associated with dysregulation or overexpression of filamin A. Ourscience is based on modulating the activity of a critical protein in the brain for patients wit...
Q2 FY2026 — expected 2026-09-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001437749-26-007962 | EDGAR | 72K words |
| 2025-03-03 | 2024-12-31 | 0001437749-25-005919 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001437749-24-005894 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0001069530-23-000009 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001069530-22-000011 | EDGAR | — |
| 2021-03-23 | 2020-12-31 | 0001069530-21-000020 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001069530-20-000009 | EDGAR | — |
| 2019-03-29 | 2018-12-31 | 0001069530-19-000019 | EDGAR | — |
| 2018-02-06 | 2017-12-31 | 0001069530-18-000004 | EDGAR | — |
| 2017-03-07 | 2016-12-31 | 0001069530-17-000008 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001437749-25-034427 | EDGAR | 25K words |
| 2025-08-14 | 2025-06-30 | 0001437749-25-026686 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001437749-25-015478 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001437749-24-033944 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001437749-24-025611 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001437749-24-016040 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001437749-23-030502 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001069530-23-000039 | EDGAR | — |
| 2023-05-01 | 2023-03-31 | 0001069530-23-000017 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0001069530-22-000058 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001069530-22-000033 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0001069530-22-000023 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-12 | 0001171843-26-001506 | EDGAR | 3K words |
| 2026-03-10 | 0001437749-26-007422 | EDGAR | — |
| 2026-02-19 | 0001171843-26-000922 | EDGAR | — |
| 2025-12-23 | 0001437749-25-038605 | EDGAR | — |
| 2025-12-18 | 0001437749-25-038313 | EDGAR | — |
| 2025-12-17 | 0001437749-25-038157 | EDGAR | — |
| 2025-12-03 | 0001437749-25-036710 | EDGAR | — |
| 2025-11-12 | 0001171843-25-007222 | EDGAR | — |
| 2025-10-24 | 0001437749-25-031674 | EDGAR | — |
| 2025-10-22 | 0001437749-25-031466 | EDGAR | — |
340 total filings indexed. 308 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001069530 |
| Ticker | FLNA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.filanatx.com |
| Listed | 2000-07-14 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report